Market Trends of Hernia Mesh Devices Industry
This section covers the major market trends shaping the Hernia Mesh Devices Market according to our research experts:
Biologic Mesh Segment is Expected to Witness Significant Growth Over the Forecast Period
Biologic mesh is mainly developed from the porcine or human dermis. It offers several advantages over synthetic ones, including its high ability to be used in a contaminated area without the fear of infection. For instance, as per the article published in the American Society of Plastic Surgeons Wolters Kluwer Health, Inc. in February 2022, the synthetic meshes used for ventral hernia repair treatment led to several infections at the surgical site, fistula formation, abdominal stiffness, and adhesion. In order to address these issues, biological meshes were developed. More recently, they have been strongly recommended for use when infection risk is elevated, and contamination levels are high. Thus, due to the several benefits associated with the aid of biological meshes over synthetic ones, the segment is expected to register high growth during the forecast period.
Additionally, the recurrence rate of hernia is significantly less with the use of reinforced biologic ovine rumen (RBOR) mesh compared to the other types, leading to its high adoption while performing hernia surgeries. For instance, as per the study published in NCBI in February 2022, the risk of complications and hernia recurrence was higher in patients receiving cross-linked porcine acellular dermal matrices (C-PADM) mesh, i.e., 52.9%, in comparison to the ones receiving reinforced biologic ovine rumen (RBOR), i.e., only 16.7%. Thus, the adoption of RBOR for hernia treatment is augmenting the segment growth.
North America is Expected to Dominate the Hernia Mesh Devices Market
North America is expected to dominate the market owing to factors such as the high prevalence of hernias, the high number of hernia repair surgeries being performed in the region, and the adoption of machine learning models in the United States for the prediction of adverse events. As per the American College of Surgeons (ACS) in April 2022, in the United States, there are four million abdominal procedures performed annually, some of which may require hernia repair. Thus, the high number of hernia repair surgeries being performed in the region is expected to drive regional growth during the forecast period.
In addition, the adoption of ML models for the prediction of hernia recurrence in the United States is also burgeoning the regional market growth. For instance, in April 2022, the University of Texas MD Anderson Cancer Center announced the launch of an ML model, which can easily predict hernia recurrence and other complications post-surgery. In the patients who had been through ventral hernia surgery, the ML model showed the following accuracy rates: 85% for forecasting hernia recurrence, 72% for forecasting surgical site occurrence, and 84% for forecasting 30-day hospital readmission. Thus, the surgical number of hernia incidence and adoption of advanced models is expected to drive the demand for hernia mesh devices market in the region.
Therefore, owing to the aforesaid factors the growth of the studied market is anticipated in the North America Region.
